Skip to main content
Main analysis: Globrands Group 2025: Cash Flow Recovered, but 2027 Is Already in the Room
ByMarch 27, 2026~8 min read

Globrands Group: How Much Cushion Is Really Left After Working Capital, Leases, and Dividends

Globrands delivered a NIS 59.5 million recovery in operating cash flow in 2025, but once lease principal, dividends, capex and debt service are included, very little real cushion remains. The covenants were met, yet that compliance still depends on tight working-capital management, short-term bank funding and added supplier-finance tools rather than on a wide cash buffer.

What Is Left After The First Screen

The main article already made the core point: 2025 brought Globrands back to respectable operating cash flow. This follow-up isolates the next question: how much of that number is actually left once working capital, lease principal, dividends and the rest of the real cash uses are pulled back into the picture.

That distinction matters because, for Globrands, reported operating cash flow and financing room are not the same thing. Cash flow from operations rose to NIS 59.5 million in 2025 from NIS 26.2 million in 2024. On a first read, that looks like a clear rebuild of cash headroom. On a second read, the year still ended with just NIS 12.2 million of cash, NIS 357.3 million of short-term bank credit, NIS 9.9 million of current lease liabilities, and only NIS 18.2 million of positive working capital. That is not an accounting quirk. It is the actual bottleneck.

To frame 2025 properly, the right bridge here is all-in cash flexibility, not normalized / maintenance cash generation. The reason is straightforward: the report does not disclose maintenance capex, and this continuation is about financing room, not about an idealized recurring-cash number. In this bridge, "lease burden" means lease-principal repayments, not total lease-related cash outflow.

Where Cash Flow Improved, And Where It Still Stayed Fragile

The recovery in operating cash flow is real. Net profit was NIS 52.7 million, non-cash adjustments added another NIS 6.9 million, and cash flow from operations reached NIS 59.5 million. But the appendix to the cash flow statement makes clear why that figure should not be mistaken for a relaxed balance sheet.

In 2025, trade receivables absorbed NIS 33.4 million, other receivables and prepaid expenses absorbed another NIS 17.3 million, and other payables reduced cash by another NIS 0.8 million. Offsetting that, inventory released NIS 18.9 million and suppliers provided NIS 18.3 million. In other words, a meaningful part of the cash-flow recovery came from tightly managed working capital rather than from a business that suddenly became light on cash.

Working-capital moves that shaped 2025 cash flow

That matters for two reasons. First, those are exactly the balance-sheet lines that also sit underneath the short-term debt-to-working-capital covenants. Second, this is a model with very little room for slippage. If receivables stretch, if inventory builds again, or if supplier financing becomes less supportive, the operating cash number can deteriorate quickly even without a dramatic change in sales.

The year-end balance sheet reinforces the point. Current assets stood at NIS 544.3 million against current liabilities of NIS 526.1 million. Formally, that is positive working capital. Economically, it is a narrow cushion relative to the size of short-term bank funding sitting underneath the model.

The Cash Bridge That Actually Matters

Once the bridge is laid out properly, 2025 looks far less generous than the operating-cash headline suggests.

Cash flow from operations came in at NIS 59.5 million. From that, Globrands paid NIS 9.1 million of lease principal and NIS 40.0 million of dividends. After just those two items, only about NIS 10.4 million remained. That is already a very different number from the headline operating-cash figure.

From there, the room all but disappeared. Reported capex was NIS 10.6 million. Repayments of long-term loans and other borrowings totaled NIS 2.5 million. Another NIS 1.0 million went to contingent consideration. Put differently, even before the acquisition of the newly consolidated subsidiary, 2025 left almost no real cash cushion behind. On that bridge, the year was roughly NIS 3.7 million negative before acquisition cash outflow. The acquisition itself added another NIS 30.1 million of cash use.

From operating cash flow to real 2025 cash headroom

That is also why year-end cash only rose to NIS 12.2 million despite NIS 59.5 million of operating cash flow. The balance was protected because short-term bank credit increased by NIS 33.6 million net during the year.

This is the central gap between reported operating cash flow and true headroom. NIS 59.5 million is a much better number than 2024. But NIS 10.4 million after lease principal and dividends, and essentially nothing after capex, is not a comfortable cash profile.

The Covenants Passed, But They Did Not Create Room

The covenants were met. That matters. But it matters just as much to see how they were met.

Against Bank A, the short-term financial debt-to-working-capital ratio stood at 90.6% versus a 95% ceiling. Against Bank B, the net short-term financial debt-to-operating-working-capital ratio stood at 90.2% against the same 95% ceiling.

Year-end covenant headroom

That creates two realities at once. There is no covenant breach, and the company did stay inside the limits. But there is no wide buffer either. The remaining room is 4.4 percentage points at Bank A and 4.8 percentage points at Bank B. In a distribution model where working capital is driven by inventory, receivables, suppliers and short-term funding, that is a cushion that requires constant discipline, not a one-off year-end pass.

The tangible-equity test tells a similar story. At both banks, Globrands ended 2025 with a tangible equity-to-balance-sheet ratio of 8.5%, and it also met the minimum tangible equity test at NIS 55 million against a required NIS 16.5 million. But 8.5% is not the kind of figure that lets the funding layer disappear from view. It says the test was passed, not that the pressure is gone.

That reading connects directly to the debt structure. Bank credit reached NIS 357.3 million at year-end, all inside current liabilities. Included in that line were NIS 14.0 million of obligations under a supplier-finance arrangement that was only entered into on December 21, 2025. At the same time, the risk note shows about NIS 361 million of bank credit and long-term bank loans carrying floating interest. So covenant compliance is resting on short-dated, rolling, interest-sensitive funding, not on a balance sheet that is comfortably self-funded.

Leases And Dividends Are Not Footnotes

There is an easy temptation to treat lease principal and dividends as secondary items that sit outside the operating story. Here, that would be the wrong read.

Lease-principal repayments were NIS 9.1 million in 2025. The balance sheet also carried NIS 9.9 million of current lease liabilities and NIS 29.9 million of non-current lease liabilities. So leases are not just an accounting presentation issue. They are a recurring draw on cash.

The same applies to the dividend. Globrands paid NIS 40.0 million of cash dividends in 2025. That was lower than NIS 57.0 million in 2024 and NIS 62.0 million in 2023, but it still consumed most of what was left after operating cash flow once lease principal was taken out. The key question is therefore not whether the company can technically distribute cash in a given year. The key question is what that distribution costs inside a capital structure that still holds only NIS 12.2 million of cash against NIS 357.3 million of short-term bank credit.

For shareholders, the implication is straightforward: the 2025 dividend was not funded out of a visibly wide surplus-cash year. It was funded out of a better operating-cash year that still depended on heavy short-term funding and tightly managed working capital. That is not automatically a problem. But it does mean the dividend did not widen the cushion. It consumed it.

Key item20242025Why it matters
Cash flow from operationsNIS 26.2mNIS 59.5mStrong headline recovery
Dividends paidNIS 57.0mNIS 40.0mStill a material cash use
Lease-principal repaymentsNIS 10.1mNIS 9.1mA recurring cash burden
Reported capexNIS 17.2mNIS 10.6mEven lower capex did not create wide room
Bank creditNIS 324.1mNIS 357.3mReliance on short-term funding increased
Cash and cash equivalentsNIS 10.9mNIS 12.2mThe buffer barely improved

Conclusion

The main article showed that cash flow recovered. This continuation shows why that still does not translate into genuine headroom. NIS 59.5 million of operating cash flow is a good number, but after lease principal and dividends only NIS 10.4 million remained, and after capex and debt service almost nothing was left. That is the difference between a business that can generate cash and a business that has already bought itself meaningful financing room.

That is also the right way to read the covenants. They passed, but at levels that still depend on tightly managed working capital, high short-term bank funding, and continued rollover of financing. The addition of NIS 14.0 million of supplier finance in late December only reinforces that point: the company expanded its funding toolkit, it did not step away from it.

Thesis now: Globrands' real 2025 cash cushion was much narrower than the operating-cash headline suggests because working capital, lease principal, dividends, capex and short-term funding still dominate the economics of headroom.

The key 2026 question is not whether the company can produce more EBITDA or another decent net-profit figure. The more important question is whether it can keep operating cash flow healthy, avoid another build in receivables and inventory, and reduce dependence on short-term funding without cutting the cash buffer back to the bone.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction